Scholarly Index
Chang‐Seok Ki
Genome and Company (South Korea); 15,435 total citations; 689 total publications; best world rank #256
Genome and Company (South Korea)
15,435Total citations
689Total publications
59H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Silk-based biomaterials and applications | Lifetime | 256 | KR 11 | 96.38 |
| Genomics and Rare Diseases | Lifetime | 946 | KR 3 | 93.97 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 791 | KR 2 | 93.93 |
| Connective tissue disorders research | Lifetime | 809 | KR 4 | 92.74 |
| Hereditary Neurological Disorders | Lifetime | 518 | KR 5 | 92.84 |
| Cerebrovascular and genetic disorders | Lifetime | 311 | KR 9 | 89.23 |
| Moyamoya disease diagnosis and treatment | Lifetime | 661 | KR 41 | 89.69 |
| Clusterin in disease pathology | Lifetime | 373 | KR 22 | 68.02 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 842 | KR 16 | 74.05 |
| Cerebrovascular and genetic disorders | 2021-2025 | 747 | KR 21 | 36.16 |